Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
![]() |
Fig. S5ABD
Edwards NA et al. (2025) |
Xtr Wt + rab5a CRISPR
NF44 (immunohistochemistry) |
|
|||||
![]() |
Fig.4.E
Nasr T et al. (2019) |
Xla Wt + gli3 MO
NF41 (immunohistochemistry) |
|
|||||
![]() |
fig.S1.d
Ossipova O et al. (2015) |
Xla Wt + vangl2 MO
NF18 (immunohistochemistry) |
|
|||||
![]() |
fig.7.e, e^1
Ossipova O et al. (2015) |
Xla Wt + dnmyo5b-GFP
NF10.5 (immunohistochemistry) |
|
|||||
![]() |
fig.7.e. e^1
Ossipova O et al. (2015) |
Xla Wt + dnmyo5b-GFP
NF10.5 (immunohistochemistry) |
|
|||||
![]() |
fig.5..f
Ossipova O et al. (2015) |
Xla Wt + vangl2 MO
NF10.5 (morphology) |
|
|||||
![]() |
fig.5..h
Ossipova O et al. (2015) |
Xla Wt + vangl2 MO
NF11 (morphology) |
|